Overview
Pharma Nord develops and manufactures dietary supplements with pharmaceutical-grade quality, whose safety and bioavailability have been confirmed by research. Its products include supplements with coenzyme Q10, selenium and zinc, omega-7, vitamin D3, and magnesium.
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2024, 202 days late).
- 202516/04/2026
- 202402/02/2026
- 202302/05/2024
- 202212/06/2023
- 202120/06/2022
- 202021/04/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Dietary supplements
- Vitamins
Website technology
- Analytics and marketing
- Meta Pixel
Trademarks
Pharma Nord currently holds no active trademarks with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2008.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| Bio-C.L.A. Duo | Z.378105 | 5, 29, 30 | Refused | – | |
| Bio-minki | Z.349792 | 5, 30 | Expired | – |
| Mark | Protected until | |
|---|---|---|
| Bio-C.L.A. Duo | – | |
| Bio-minki | – |
Authorized Representatives
Manner of representation
If the management board is a one-person management board, a member of the management board is authorized to submit declarations of will and sign on behalf of the company independently. If the management board is a multi-member management board, the joint action of two members of the management board is required to submit declarations of will and sign on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Pharma Nord Aps | 100 | $13,506.21 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2000-11-06.
07 2360 0005 0000 0045 5030 3966
32 1440 1101 0000 0000 0141 0318- 44 1440 1101 0000 0000 0141 0296
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $233.5K$233,518 |
Buildings and premises | $132.7K$132,675 |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 1, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1,507$1,507 | Prezydent Miasta Stołecznego Warszawy |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Natu Caresp. z o.o. | $3,260,132.15 | natu.care | ||
| Balancesp. z o.o. | $3,003,422.23 | balance.pl | ||
| Pikadasp. z o.o. | $1,903,088.18 | apteka-propharma.pl | ||
| Akuna Polskasp. z o.o. | $2,025,454.04 | akuna.pl | ||
| Solve Labssp. z o.o. | $1,507,786.28 | solvelabs.eu | ||
| Medikathasp. z o.o. | $1,135,118.02 | sklep.probiosfera.pl | ||
| Nature Sciencesp. z o.o. | $671,693.61 | naturescience.eu | ||
| UP Health Pharmasp. z o.o. | $511,121.49 | uphealthpharma.pl | ||
| STR Nordic Polskasp. z o.o. | $493,189.96 | strnordic.pl | ||
| QILOsp. z o.o. | $358,545.45 | qilo.pl |
Change history
| Date | Event | |
|---|---|---|
| 2003-03-24 | Address change (Nowowiśniowa 2, 04-505, Warszawa → Zwoleńska 24c, 04-761, Warszawa) | |
| 2003-03-24 | Share capital increase (4,000.00 PLN → 50,000.00 PLN) | |
| 2003-03-24 | Name change (P.n. Polska → Pharma Nord) | |
| 2002-01-31 | Entered in the register |
FAQ
Last updated: 2026-10-07